All In MedTech

Device Trial Radar · NCT01401088

Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma

Last checked: Nov 20, 2026Latest source record: Jan 3, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

30

Planned (sponsor's estimate)

Start

Jul 2011

Primary completion

Nov 2013

Study completion Dec 2013

Sponsor

Lead sponsor
AurolabAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 25, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of Aurolab Artificial Drainage Implant (AADI) on intraocular pressure reduction in patients with refractory glaucoma.

Conditions

  • Glaucoma

Interventions

  • Artificial drainage implantDevice

    Artificial drainage implant is used for intra ocular pressure reduction in patient with refractory glaucoma

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intra Ocular Pressure (IOP)Time frame: One year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Aravind Eye Hospital

    Madurai, Tamil Nadu, India · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.